SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VARANI, Katia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 28.820
EU - Europa 8.661
AS - Asia 5.306
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 19
OC - Oceania 16
AF - Africa 4
Totale 42.847
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.790
CN - Cina 3.282
UA - Ucraina 2.273
DE - Germania 1.938
TR - Turchia 1.755
IT - Italia 1.450
GB - Regno Unito 932
SE - Svezia 741
FI - Finlandia 514
PL - Polonia 315
RU - Federazione Russa 210
FR - Francia 129
HK - Hong Kong 97
VN - Vietnam 83
BE - Belgio 67
CA - Canada 26
NL - Olanda 25
IN - India 21
IR - Iran 20
EU - Europa 18
AU - Australia 11
AT - Austria 10
JP - Giappone 10
RO - Romania 9
CL - Cile 8
ES - Italia 8
SG - Singapore 8
BR - Brasile 7
CH - Svizzera 6
CZ - Repubblica Ceca 5
IE - Irlanda 5
NZ - Nuova Zelanda 5
KR - Corea 4
MX - Messico 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BD - Bangladesh 3
GR - Grecia 3
HR - Croazia 3
ID - Indonesia 3
IL - Israele 3
PK - Pakistan 3
TW - Taiwan 3
DZ - Algeria 2
IM - Isola di Man 2
IQ - Iraq 2
MA - Marocco 2
MD - Moldavia 2
NO - Norvegia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
BG - Bulgaria 1
BO - Bolivia 1
CO - Colombia 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MC - Monaco 1
ME - Montenegro 1
MY - Malesia 1
SA - Arabia Saudita 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
Totale 42.847
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.958
Fairfield 3.394
Jacksonville 2.602
Chandler 2.498
Houston 2.382
Ann Arbor 2.135
Ashburn 1.737
Wilmington 1.418
Seattle 1.323
Cambridge 1.109
Izmir 893
Nanjing 781
Beijing 662
Princeton 585
Ferrara 439
Boardman 413
Warsaw 312
San Diego 301
Milan 287
Nanchang 250
Shanghai 248
Shenyang 232
Dearborn 179
Bremen 167
Changsha 148
Hebei 148
New York 146
Tianjin 143
Addison 140
Jiaxing 136
San Mateo 99
Hong Kong 94
Falls Church 90
Jinan 86
Norwalk 83
Zhengzhou 82
Dong Ket 81
Kunming 77
Mountain View 70
Brussels 66
Auburn Hills 59
Orange 58
London 57
Düsseldorf 54
Ningbo 53
Redwood City 49
Philadelphia 47
Guangzhou 43
Washington 43
Des Moines 39
Tappahannock 37
Los Angeles 36
Taizhou 34
Augusta 32
Bologna 31
Helsinki 30
Indiana 30
Chicago 28
Hangzhou 28
Verona 26
Lanzhou 25
Redmond 21
Munich 19
Haikou 17
Hefei 17
Leawood 17
Ardabil 16
Ferrara di Monte Baldo 16
Kilburn 16
Rome 16
Changchun 12
Bari 11
Chiswick 11
Padova 10
Hounslow 8
Monmouth Junction 8
San Francisco 8
Taiyuan 8
Edinburgh 7
Florence 7
Fuzhou 7
Mcallen 7
New Bedfont 7
Tokyo 7
Montebelluna 6
Montréal 6
Toronto 6
Acton 5
Cagliari 5
Kitzbuhel 5
Parma 5
Prescot 5
Vienna 5
Walnut 5
Xian 5
Yellow Springs 5
Aversa 4
Catania 4
Chatsworth 4
Este 4
Totale 31.185
Salva come PNG Salva come JPEG
Nome #
1,3-Dipropyl-8-(1-phenylacetamide-1H-pyrazol-3-yl)-xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists 283
Effect of the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical responses in mice. In vitro and in vivo pharmacological studies 218
A glance at adenosine receptors: Novel target for antitumor therapy 191
1-Methyl and 1-(2-hydroxyalkyl)-5-(3-alkyl/cycloalkyl/phenyl/naphthylureido)-1H-pyrazole-4-carboxylic acid ethyl esters as potent human neutrophil chemotaxis inhibitors 189
Inhibition of A2A Adenosine Receptor Signaling in Cancer Cells Proliferation by the Novel Antagonist TP455 184
Novel halogenated derivates of JWH-018: Behavioral and binding studies in mice 177
Alterazioni dei recettori alfa(2) adrenergici delle piastrine umane nell'ipertensione essenziale 175
The A3 adenosine receptor: history and perspectives 158
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neurological and neurochemical responses in mice 156
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 154
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 151
Cannabinoid CB2 receptor attenuates morphine-induced inflammatory responses in activated microglial cells 151
A1 and A3 adenosine receptors inhibit LPS-induced hypoxia-inducible factor-1 accumulation in murine astrocytes 149
Synthesis and Structure Activity Relationship Investigation of Triazolo[1,5-a]pyrimidines as CB2 Cannabinoid Receptor Inverse Agonists 149
Recettori e trasduzione del segnale 147
A3 Adenosine Receptors as Modulators of Inflammation: From Medicinal Chemistry to Therapy 143
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 143
History and perspectives of A2A adenosine receptor antagonists as potential therapeutic agents 140
Positive allosteric modulation of A1 adenosine receptors as a novel and promising therapeutic strategy for anxiety 139
Psychostimulant effect of the synthetic cannabinoid JWH-018 and AKB48. Behavioural, neurochemical and Dopamine transporter scan imaging studies in mice 138
Binding and signaling studies disclose a potential allosteric site for cannabidiol in cannabinoid CB2 receptors 138
Pathological overproduction: the bad side of adenosine 138
Pharmacology of Adenosine Receptors: The State of the Art 137
Adenosine analogs and electromagnetic fields inhibit prostaglandin E2 release in bovine synovial fibroblasts 136
Current status of A1 adenosine receptor allosteric enhancers 136
Adenosine receptors and human melanoma 133
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 133
New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. 131
Water-Soluble Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines as Human A3 Adenosine Receptor Antagonists 131
Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor 131
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 130
Adenosine receptor targeting in health and disease 129
New 2-heterocyclyl-imidazo[2,1- i ]purin-5-one derivatives as potent and selective human A 3 adenosine receptor antagonists 129
Receptor binding at two different temperatures to discriminate agonist and antagonist behaviour of adenosine A1 receptor ligands in rat brain 127
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells. 125
Multiple sclerosis lymphocytes upregulate A(2A) adenosine receptors that are antiinflammatory when stimulated 125
The activation of μ-opioid receptor potentiates LPS-induced NF-kB promoting an inflammatory phenotype in microglia 125
Pulsed Electromagnetic Field Exposure Reduces Hypoxia and Inflammation Damage in Neuron-Like and Microglial Cells 123
A Consensus Panel Review of Central Nervous System Effects of the Exposure to Low-Intensity Extremely Low-Frequency Magnetic Fields 123
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[(4- arylpiperazin-1-yl)methyl]-5-substituted-thiophenes. Effect of the 5-modification on allosteric enhancer activity at the A1 adenosine receptor 123
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 121
Comparison of Prazosin, Terazosin and Tamsulosin: Functional and Binding Studies in Isolated Prostatic and Vascular Human Tissues. 121
null 121
A(2A) adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients 120
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 119
One-pot reaction to obtain N,N'-disubstituted guanidines of pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold as human A3 adenosine receptor antagonists 119
Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A2A Adenosine Receptor Inverse Agonists with Antinociceptive Activity 119
6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors 118
Repeated dosing with NCX1404, a nitric oxide-donating pregabalin, re-establishes normal nociceptive responses in mice with streptozotocin-induced painful diabetic neuropathy 118
Modulation of metalloproteinase-9 in U87MG glioblastoma cells by A3 adenosine receptors 118
Adenosine modulates vascular endothelial growth factor expression via hypoxiainducible factor-1 in human glioblastoma cells. 117
2-Arylpyrazolo[4,3-d]pyrimidin-7-amino derivatives as new potent and selective human A3 adenosine receptor antagonists. Molecular modeling studies and pharmacological evaluation 117
A(2B) adenosine receptors stimulate IL-6 production in primary murine microglia through p38 MAPK kinase pathway 117
N-6-[(Hetero)aryl/(cyclo)alkyl-carbamoyi-methoxy-phenyl]-(2chloro)-5 '-N-ethylearboxamido-adenosines: The first example of adenosine-related structures with potent agonist activity at the human A(2B) adenosine receptor 116
Alteration of A3 adenosine receptors in human neutrophils and low frequency electromagnetic fields 116
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 116
Synthesis and pharmacology of 6-substituted benztropines: Discovery of novel dopamine uptake inhibitors possessing low binding affinity to the dopamine transporter 116
Ala scan analogues of HOE 140. Synthesis and biological activities 115
A3 adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study 115
Adenosine as a Multi-Signalling Guardian Angel in Human Diseases: When, Where and How Does it Exert its Protective Effects? 115
Role and function of A2A and A3 adenosine receptors in patients with ankylosing spondylitis, psoriatic arthritis and rheumatoid arthritis 114
Expression and functional role of adenosine receptors in regulating inflammatory responses in human synoviocytes. 114
null 113
Binding thermodynamics at A1 and A2A adenosine receptors 113
Biochemical characterization of A1 adenosine receptors: experimental evaluation of their binding and intrinsic activity parameters 113
MODULATION OF THE AKT/RAS/RAF/MEK/ERK PATHWAY BY A3 ADENOSINE RECEPTOR 113
null 113
Electromagnetic fields (EMFs) and adenosine receptors modulate prostaglandin E(2) and cytokine release in human osteoarthritic synovial fibroblasts 113
Thermodynamics of A2B adenosine receptor binding discriminates agonistic from antagonistic behaviour. 112
Design, synthesis, and preliminary pharmacological evaluation of new quinoline derivatives as nicotinic ligands 112
null 112
A2A and A3 adenosine receptor expression in rheumatoid arthritis: upregulation, inverse correlation with disease activity score and suppression of inflammatory cytokine and metalloproteinase release 112
Biological activity of for-Met-Leu-Phe-OMe analogs: relevant substitutions specifically trigger killing mechanisms in human neutrophils 112
Effects of doxazosin and propranolol on A2A adenosine receptors in essential hypertension 111
Adenosine receptors as mediators of both cell proliferation and cell death of cultured human melanoma cells 111
Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide 111
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 111
F638 a nitric oxide (NO)-donating gabapentin, NCX 1236, reverses the development of mechanical allodynia in streptozotocin-treated diabetic mice. 111
Medicinal Chemistry of A3 Adenosine Receptor Modulators: Pharmacological Activities and Therapeutic Implications 111
Synthesis and biological evaluation of 2-amino-3-(4-chlorobenzoyl)-4-[N- (substituted) piperazin-1-yl]thiophenes as potent allosteric enhancers of the A1 adenosine receptor 111
Functional tissue engineering in articular cartilage repair: is there a role for electromagnetic biophysical stimulation? 111
New potent and selective human adenosine A3 receptor antagonists. 111
The A3 adenosine receptor: an enigmatic player in cell biology. 110
Adenosine signaling contributes to ethanol-induced fatty liver in mice 110
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 110
Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter 110
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 110
7-Oxo-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxamides as Selective CB2 Cannabinoid Receptor Ligands: Structural Investigations around a Novel Class of Full Agonists 110
Medicinal chemistry, pharmacology, and potential therapeutic benefits of cannabinoid CB2receptor agonists 110
Characterization of adenosine receptors in bovine chondrocytes and fibroblast-like synoviocytes exposed to low frequency low energy pulsed electromagnetic fields. 109
Adenosine modulates vascular endothelial growth factor expression via hypoxia-inducible factor-1 in human glioblastoma cells 109
Asymmetrical nitrido tc-99m heterocomplexes as potential imaging agents for benzodiazepine receptors 109
Effect of low frequency electromagnetic fields on A2A adenosine receptors in human neutrophils. 109
The role of adenosine receptors in rheumatoid arthritis. 109
Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors 109
A3 adenosine receptor activation inhibits cell proliferation via phosphatidylinositol 3-kinase/Akt-dependent inhibition of the extracellular signal-regulated kinase 1/2 phosphorylation in A375 human melanoma cells 108
Changes of peripheral A2A adenosine receptors in chronic heart failure and cardiac transplantation 108
Structure-activity relationship studies of a new series of imidazo[2,1-f]purinones as potent and selective A(3) adenosine receptor antagonists. 108
Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation 108
Effects of A1 and A2A adenosine receptor ligands in mouse acute models of pain 108
Totale 12.721
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.528
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.199
Totale 149.727
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194.307 0 0 0 0 0 0 0 0 0 999 1.090 2.218
2019/20208.757 1.602 257 238 1.201 502 1.027 757 906 636 1.021 463 147
2020/20216.868 600 670 242 788 344 711 276 826 165 951 888 407
2021/20225.145 126 552 340 225 245 210 232 269 193 432 731 1.590
2022/20235.734 592 432 176 795 954 821 269 458 700 46 296 195
2023/20241.977 289 377 142 83 316 343 136 209 57 25 0 0
Totale 43.499